The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Katherine Wolkoff for The New York Times Supported by By Lisa Miller Lisa Miller interviewed more than two dozen people about the ... to seriously consider taking Zepbound, one of the new ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Both groups followed a reduced-calorie diet and exercise plan ... your healthcare provider for a full list of side effects. Zepbound is a GLP-1 agonist containing tirzepatide, the same active ...

Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study reports. Patients had a 72% lower risk of developing serious complications of liver ...